Advertisement

Evidence-Based Treatment of Pediatric Obsessive-Compulsive Disorder

  • Eric A. Storch
  • Michael Larson
  • Jennifer Adkins
  • Gary R. Geffken
  • Tanya K. Murphy
  • Wayne K. Goodman
Chapter
Part of the Issues in Clinical Child Psychology book series (ICCP)

Keywords

Adolescent Psychiatry Compulsive Behavior Anxious Arousal Exposure Exercise Compulsive Hoarding 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramowitz, J. S. (1997). Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review. Journal of Consulting and Clinical Psychology, 65, 44–52.PubMedCrossRefGoogle Scholar
  2. Abramowitz, J. S., Franklin, M. E., Schwartz, S. A., & Furr, J. M. (2003). Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology, 71, 1049–1057.PubMedCrossRefGoogle Scholar
  3. Abramowitz, J. S., Franklin, M. E., Street, G. P., Kozak, M. J., & Foa, E. B. (2000). Effects of comorbid depression on response to treatment for obsessive-compulsive disorder. Behavior Therapy, 31, 517–528.CrossRefGoogle Scholar
  4. Araujo, L. A., Ito, L. M., & Marks, I. (1996). Early compliance and other factors predicting outcome of exposure for obsessive-compulsive disorder. British Journal of Psychiatry, 169, 747–752.PubMedGoogle Scholar
  5. Barrett, P., Farrell, L., Dadds, M., & Boulter, N. (2005). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: Long-term follow-up and predictors of outcome. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 1005–1014.PubMedCrossRefGoogle Scholar
  6. Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: A controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 46–62.PubMedCrossRefGoogle Scholar
  7. Benazon, N. R., Ager, J., & Rosenberg, D. R. (2002). Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: An open trial. Behavior Research and Therapy, 40, 529–539.CrossRefGoogle Scholar
  8. Black, D. W., Monahan, P., Gable, J., Blum, N., Clancy, G., & Baker, P. (1998). Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. Journal of Clinical Psychiatry, 59, 420–425.PubMedGoogle Scholar
  9. Center for Drug Evaluation and Research (2005). Worsening depression and suicidality in patients being treated with antidepressant medications. Retrieved April 10, 2005, from www.fda.gov/cder/drug/antidepressants/AntidepressanstPHA.htm.Google Scholar
  10. Chambless, D. L., & Steketee, G. (1999). Expressed emotion and behavior therapy outcome: A prospective study with obsessive compulsive and agoraphobic outpatients. Journal of Consulting and Clinical Psychology, 67, 658–665.PubMedCrossRefGoogle Scholar
  11. Committee on Safety of Medicines. (2004). Use of selective serotonin reuptake inhibitors (SSRIs) in children and adolescents with major depressive disorder (MDD)—Only fluoxetine (Prozac) shown to have a favourable balance of risks and benefits for the treatment of MDD in the under 18s. Retrieved April 20, 2005, from http://medicines.mhra.gov.uk ourwork/monitorsafequalmed/ safetymessages/ssris_spc_061204.pdf.Google Scholar
  12. Cook, E. H., Wagner, K. D., March, J. S., Biederman, J., Landau, P., Wolkow, R., et al. (2001). Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1175–1181.PubMedCrossRefGoogle Scholar
  13. Cottraux, J., Messy, P., Marks, I. M., Mollard, E., & Bouvard, M. (1993). Predictive factors in the treatment of obsessive-compulsive disorders with fluvoxamine and/or behavior therapy. Behavioural Psychotherapy, 21, 45–50.CrossRefGoogle Scholar
  14. de Hann, E., Hoogduin, K. A. L., Buitelaar, J. K., & Keijesers, G. P. J. (1998). Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1022–1029.Google Scholar
  15. de Haan, E., van Oppen, P., van Balkom, A. J., Spinhoven, P., Hoogduin, K. A., & Van Dyck, R. (1997). Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy. Acta Psychiatrica Scandinavica, 96, 354–361.PubMedCrossRefGoogle Scholar
  16. DeVeaugh-Geiss, J., Moroz, G., Biederman, J. B., Cantwell, D., Fontaine, R., Greist, J. H., et al. (1992). Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: A multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 45–49.PubMedCrossRefGoogle Scholar
  17. Dougherty, D. D., Rauch, S. L., & Jenike, M. A. (2002). Pharmacological treatments for obsessive compulsive disorder. In A Guide to Treatments That Work, 2nd ed. (pp. 387–410). New York: Oxford University Press.Google Scholar
  18. Douglass, H. M., Moffitt, T. E., Dar, R., McGee, R., & Silva, P. (1995). Obsessive-compulsive disorder in a birth cohort of 18-year-olds: Prevalence and predictors. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1424–1431.PubMedCrossRefGoogle Scholar
  19. Ellingrod, V. L. (1998). Pharmacotherapy of primary obsessive-compulsive disorder: Review of the literature. Pharmacotherapy, 18, 936–960.PubMedGoogle Scholar
  20. Figueroa, Y., Rosenberg, D. R., Birmaher, B., & Keshavan, M. S. (1998). Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 8, 61–67.PubMedGoogle Scholar
  21. Fischer, D., Himle, J. A., & Hanna, G. L. (1998). Group behavioral therapy for adolescents with obsessive-compulsive disorder: Preliminary outcomes. Research in Social Work, 8, 629–636.CrossRefGoogle Scholar
  22. Flament, M. F., Rapoport, J. L., Berg, C. J., Sceery, W., Kilts, C., Mellstrom, B., et al. (1985). Clomipramine treatment of childhood obsessive-compulsive disorder: A double-blind controlled study. Archives of General Psychiatry, 46, 1088–1092.Google Scholar
  23. Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., et al. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 162, 151–161.PubMedCrossRefGoogle Scholar
  24. Franklin, M. E., Kozak, M. J., Cashman, L. A., Coles, M. E., Rheingold, A. A., & Foa, E. (1998). Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: An open clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 412–419.PubMedCrossRefGoogle Scholar
  25. Gallant, J., Storch, E. A., Valderhaug, R., & Geffken, G. R. (2005). School Psychologists’ Views and Management of Obsessive-Compulsive Disorder in Children and Adolescents. Unpublished manuscript.Google Scholar
  26. Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Farrell, C., Wagner, K. D., et al. (2003a). Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: Is the use of exclusion criteria empirically supported in randomized clinical trials? Journal of Child and Adolescent Psychchopharmacology, 13S, S19–29.CrossRefGoogle Scholar
  27. Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T., et al. (2003b). Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. American Journal of Psychiatry, 160, 1919–1928.CrossRefGoogle Scholar
  28. Geller, D. A., Hoog, S. L., Heiligenstein, J. H., Ricardi, R. K., Tamura, R., Kluszynski, S., et al. (2001). Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 773–779.PubMedCrossRefGoogle Scholar
  29. Gold-Steinberg, S., & Logan, D. (1999). Integrating play therapy in the treatment of children with obsessive-compulsive disorder. American Journal of Orthopsychiatry, 69, 495–503.Google Scholar
  30. Goodman, W.K., Price, L.H., Rasmussen, S.A., Mazure, C., Fleischman, R.L., Hill, C.L., et al. (1989). The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006–1011.PubMedGoogle Scholar
  31. Grados, M. A., & Riddle, M. A. (2001). Pharmacological treatment of childhood obsessive-compulsive disorder: From theory to practice. Journal of Clinical Child Psychology, 30, 67–79.PubMedCrossRefGoogle Scholar
  32. Keijsers, G. P., Hoogduin, C. A., & Schaap, C. P. (1994). Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. British Journal of Psychiatry, 165, 781–786.PubMedGoogle Scholar
  33. Larson, M. J., Storch, E. A., Lewin, A. B., Geffken, G. R., Murphy, T. K., & Goodman, W. K. (2005). Update on the treatment of pediatric obsessive-compulsive disorder. Current Psychiatry Reviews, 1, 281–291.CrossRefGoogle Scholar
  34. Leonard, H. L., Swedo, S. E., Lenane, M. C., Rettew, D. C., Hamburger, S. D., Bartko, J. J., et al. (1993). A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Archives of General Psychiatry, 50, 429–439.PubMedGoogle Scholar
  35. Lewin, A. B., Storch, E. A., Adkins, J. W., Murphy, T. K., & Geffken, G. R. (2005). Current directions in pediatric obsessive-compulsive disorder. Pediatric Annals, 34, 128–134.PubMedGoogle Scholar
  36. Lewin, A. B., Storch, E. A., Merlo, L. J., Adkins, J. W., Murphy, T. K., & Geffken, G. R. (in press). Intensive cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: A treatment protocol for mental health providers. Psychological Services.Google Scholar
  37. Liebowitz, M. R., Turner, S. M., Piacentini, J., Beidel, D. C., Clarvit, S. R., Davies, S. O., et al. (2002). Fluoxetine in children and adolescents with OCDL: A placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1431–1438.PubMedCrossRefGoogle Scholar
  38. March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., et al. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized control trial. Journal of the American Medical Association, 280, 1752–1756.PubMedCrossRefGoogle Scholar
  39. March, J. S., Franklin, M. E., Nelson, A., & Foa, E. (2001). Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder. Journal of Clinical Child Psychology, 30, 8–18.PubMedCrossRefGoogle Scholar
  40. March, J. S., & Mulle, K. (1998). OCD in Children and Adolescents: A Cognitive Behavioral Treatment Manual. New York: Guilford Press.Google Scholar
  41. March, J. S., Mulle, K., & Herbel, B. (1994). Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: An open trial of a new protocol-driven treatment package. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 333–341.PubMedCrossRefGoogle Scholar
  42. Mataix-Cols, D., Marks, I. M., Greist, J. H., Kobak, K. A., & Baer, L. (2002). Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: Results from a controlled trial. Psychotherapy and Psychosomatics, 71, 255–262.PubMedCrossRefGoogle Scholar
  43. McGuire, P. K., Bench, C. J., Frith, C. D., Marks, I. M., Frackowiak, R. S., & Dolan, R. J. (1994). Functional anatomy of obsessive-compulsive phenomena. British Journal of Psychiatry, 164, 459–468.PubMedGoogle Scholar
  44. Murphy, T. K., Sajid, M., Soto, O., Shapira, N., Edge, P., Yang, M., et al. (2004). Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biological Psychiatry, 55, 61–68.PubMedCrossRefGoogle Scholar
  45. Obsessive-Compulsive Foundation. http://www.ocfoundation.org/ocf1130d.htm; accessed on December 18, 2004.Google Scholar
  46. Obsessive-Compulsive Foundation. http://www.ocfoundation.org/1003/index. html; acces-sed on October 19, 2005.Google Scholar
  47. Pediatric OCD Treatment Study Team (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. Journal of the American Medical Association, 292, 1969–1976.Google Scholar
  48. Piacentini, J., Bergman, R. L., Jacobs, C., McCracken, J., & Kretchman, J. (2002). Open trial of cognitive-behavioral therapy for childhood obsessive-compulsive disorder. Journal of Anxiety Disorders, 16, 207–219.PubMedCrossRefGoogle Scholar
  49. Piacentini, J., Bergman, R. L., Keller, M., & McCracken, J. (2003). Functional impairment in children and adolescents with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 13S-1, S61–S69.CrossRefGoogle Scholar
  50. Piacentini, J., Gitow, A., Jaffer, M., Graae, F., & Whitaker, A. (1994). Outpatient behavioral treatment of child and adolescent obsessive-compulsive disorder. Journal of Anxiety Disorders, 8, 277–289.CrossRefGoogle Scholar
  51. Piacentini, J., & Langley, A. K. (2004). Cognitive-behavioral therapy for children who have obsessive-compulsive disorder. Journal of Clinical Psychology, 60, 1181–1194.Google Scholar
  52. Practice Parameters (1998). Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37S, 27S–45S.Google Scholar
  53. Rapoport, J. L., Inoff-Germain, G., Weissman, M. M., Greenwald, S., & Narrow, W. E. (2000). Childhood obsessive-compulsive disorder in the NIMH MECA study: Parent versus child identification of cases. Methods for the Epidemiology of Child and Adolescent Mental Disorders. Journal of Anxiety Disorders, 14, 535–548.PubMedCrossRefGoogle Scholar
  54. Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H. M., Claghorn, J. L., Gaffney, G., et al. (2001). Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 222–229.PubMedCrossRefGoogle Scholar
  55. Riddle, M. A., Scahill, L., King, R., Harding, M., Anderson, G., Ort, S. I., et al. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1062–1069.PubMedCrossRefGoogle Scholar
  56. Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). Children’s Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 844–852.PubMedCrossRefGoogle Scholar
  57. Simeon, J. G., Thatte, S., & Wiggins, D. (1990). Treatment of adolescent obsessive-compulsive disorder with clomipramine-fluoxetine combination. Psychopharmacological Bulletin, 26, 285–290.Google Scholar
  58. Steketee, G., & Frost, R. (2003). Compulsive hoarding: Current status of the research. Clinical Psychology Review, 23, 905–927.PubMedCrossRefGoogle Scholar
  59. Steketee, G., & Shapiro, L. J. (1995). Predicting behavioral treatment outcome for agoraphobia and obsessive-compulsive disorder. Clinical Psychology Review, 15, 315–346.CrossRefGoogle Scholar
  60. Storch, E. A. (2005a). But is it OCD? A guide to detection and effective treatment. Contemporary Pediatrics, 22(11), 58–70.Google Scholar
  61. Storch, E. A. (2005b). Update on childhood anxiety. Pediatric Annals, 34, 78–81.Google Scholar
  62. Storch, E. A., & Geffken, G. R. (2004). Intensive Cognitive Behavior Therapy for Pediatric Obsessive-Compulsive Disorder. Paper presented at the Anxiety Disorders Association of America, Miami, FL.Google Scholar
  63. Storch, E. A., Geffken, G. R., Merlo, L. J., Mann, G., Duke, D., Munson, M., Adkins, J., Grabill, K., Murphy, T. K., & Goodmann, W. K., (2007). Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder: Comparison of Intensive and Weekly Approaches. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 469–478.PubMedCrossRefGoogle Scholar
  64. Storch, E. A., Gerdes, A., Atkins, J., Geffken, G. R., Star, J., & Murphy, T. (2004). Behavioral treatment of child with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 510–511.PubMedCrossRefGoogle Scholar
  65. Storch, E. A., & Merlo, L. J. (2006). Evaluation and treatment of the patient with obsessive-compulsive disorder. Journal of Family Practice, 55, 329–333.PubMedGoogle Scholar
  66. Task Force on Promotion and Dissemination of Psychological Procedures (1995). Training in and dissemination of empirically-valid psychological treatments: Report and recommendations. Clinical Psychologist, 48, 3–23.Google Scholar
  67. Thienemann, M., Martin, J., Cregger, B., Thompson, H. B., & Dyer-Friedman, J. (2001). Manual-driven group cognitive-behavioral therapy of adolescents with obsessive-compulsive disorder: A pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1254–1260.PubMedCrossRefGoogle Scholar
  68. Thomsen, P. H. (1998). Obsessive-compulsive disorder in children and adolescents. Clinical guidelines. European Journal of Child & Adolescent Psychiatry, 7, 1–11.CrossRefGoogle Scholar
  69. Thoren, P., Asberg, M., & Cronholm, B. (1980). Clomipramine treatment of obsessive compulsive disorder: A controlled clinical trial. Archives of General Psychiatry, 37, 1281–1285.PubMedGoogle Scholar
  70. Treadwell, K., & Tolin, D. (2007). Clinical challenges in the treatment of pediatric OCD. In E. A. Storch, G. Geffken, & T. Murphy (Eds.), Handbook of Child and Adolescent Obsessive-Compulsive Disorder. Mahwah, NJ: Lawrence Erlbaum, 273–294.Google Scholar
  71. Ursu, S., Stenger, V. A., Shear, M. K., Jones, M. R., & Carter, C. S. (2003). Overactive action monitoring in obsessive-compulsive disorder: Evidence from functional magnetic resonance imaging. Psychological Science, 14, 347–353.PubMedCrossRefGoogle Scholar
  72. Waters, T., Barrett, P., & March, J. S. (2001). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: An open clinical trial. American Journal of Psychotherapy, 55, 105–113.Google Scholar
  73. Wever, C., & Rey, J. (1997). Juvenile obsessive-compulsive disorder. Australia New Zealand Journal of Psychiatry, 31, 105–113.Google Scholar
  74. Zak, J. P., Miller, J. A., Jr., Sheehan, D. V., & Fanous, B. S. (1988). The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder. Journal of Clinical Psychiatry, 49S, 23–29.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Eric A. Storch
    • 1
    • 2
  • Michael Larson
    • 3
  • Jennifer Adkins
    • 1
  • Gary R. Geffken
    • 1
    • 2
    • 3
  • Tanya K. Murphy
    • 1
  • Wayne K. Goodman
    • 1
  1. 1.Department of PsychiatryUniversity of Florida
  2. 2.Department of PediatricsUniversity of Florida
  3. 3.Department of Clinical and Health PsychologyUniversity of Florida

Personalised recommendations

Cite chapter

Buy options